Abstract
Emery-Dreifuss muscular dystrophy (EMD) is characterised by (1) early contractures of the Achilles tendons, elbows, and postcervical muscles, (2) slowly progressive muscle wasting and weakness with a predominantly humeroperoneal distribution in the early stages, and (3) cardiomyopathy with conduction defects and risk of sudden death. Inheritance is usually X linked recessive but can be autosomal dominant. Family linkage studies have mapped X linked EMD to the distal long arm of the X chromosome but precise genetic localisation has been hampered by the rarity of this condition. We report three new families with X linked Emery-Dreifuss muscular dystrophy studied with DNA markers from Xq27-qter and three previously published families typed for additional markers.
No recombination was observed with the red/green cone pigment locus, RGCP (lod score, Z=2 46), the factor VIII coagulant gene locus, F8C (Z = 6 39), or with DXS115 (Z = 4 94). Two recombinants were observed which mapped EMD distal to DXS15 (DX13) and DXS52 (Stl4) respectively. Multipoint linkage analysis gave odds exceeding 200:1 for EMD being distal to these markers. A multipoint analysis incorporating published data gave the map cen-DXS304-9cM-DXS15-3cM-DXS52-2 cM-(RGCP,EMD)-3cM-F8C-2cM-DXS115 Family 3 from Turkey was evaluated by FD. The diagnosis of EMD was based on the findings in the three affected males II-4, II-5, and III20 of (1) childhood onset of slowly progressive muscle wasting and weakness with a scapulohumeroperoneal distribution, (2) early contractures of the Achilles tendons, elbows, and neck muscles, and (3) cardiac conduction defects (necessitating cardiac pacemaker insertion in II4 and II5). Serum creatine kinase levels were normal or mildly raised. A muscle biopsy in II-5 showed dystrophic changes. The pedigree shows unequivocal X linked inheritance. Full details of this family will be published elsewhere.
Methods
Blood samples were obtained from available family members, DNA extracted by routine methods, and DNA polymorphisms analysed by Southern analysis or the polymerase chain reaction using standard protocols. The families were typed for the DNA markers DXS304 (probe U6-2/ TaqI restriction digest), DXS52 (Stl4-1/TaqI), DXS15 (DX13/BglII), RGCP (HS7/SacI), F8C (pl 14.12/BclI), and DXSI15 (767/BstXI) as detailed elsewhere. '3 Additional linkage data were obtained by completing the typing of the above markers in two families we have reported previously5 (EMD Consortium families 5 and 612) and in a carrier mother was dead and could have been homozygous at these loci. In the present study these results were confirmed on repeat blood samples and additional typing showed that they were also recombinant for the more proximal marker DXS304 (U6.2) but had the same marker patterns for RGCP and DXS115. Consortium family 9 showed a recombinant between EMD and DXS15 as previously reported9 with two affected brothers having different restriction fragment patterns at this locus. More proximal markers were also recombinant, DXS52 was uninformative, and F8C was non-recombinant. In the present study these results were confirmed on repeat blood samples and additional typing showed that RGCP was non-recombinant.
For the multipoint analysis we used the marker order DXS304 (proximal), DXS15, DXS52, RGCP, F8C, DXS115 (distal) with recombination fractions of 0 09, 0 03, 0 02, 0 03, 0 02, respectively, calculated by multiple pairwise analysis of published linkage data. '9 This order is consistent with recent physical mapping data20 except that the order of DXS15 and DXS52 is not well established. 
